Measured before anti-TB treatment through both immunoturbidometric assay with Dimension RXL analyzer from Dade-Behring (Deerfield, IL, USA—laboratory-based high-sensitivity method) and immunoassay POC (NycoCard CRP test—Axis-Shield, Oslo, Norway). This evidence concerns the gene CRP and tuberculosis.